Literature DB >> 27929347

Comparing exponential and exponentiated models of drug demand in cocaine users.

Justin C Strickland1, Joshua A Lile1, Craig R Rush1, William W Stoops1.   

Abstract

Drug purchase tasks provide rapid and efficient measurement of drug demand. Zero values (i.e., prices with zero consumption) present a quantitative challenge when using exponential demand models that exponentiated models may resolve. We aimed to replicate and advance the utility of using an exponentiated model by demonstrating construct validity (i.e., association with real-world drug use) and generalizability across drug commodities. Participants (N = 40 cocaine-using adults) completed Cocaine, Alcohol, and Cigarette Purchase Tasks evaluating hypothetical consumption across changes in price. Exponentiated and exponential models were fit to these data using different treatments of zero consumption values, including retaining zeros or replacing them with 0.1, 0.01, or 0.001. Excellent model fits were observed with the exponentiated model. Means and precision fluctuated with different replacement values when using the exponential model but were consistent for the exponentiated model. The exponentiated model provided the strongest correlation between derived demand intensity (Q0) and self-reported free consumption in all instances (Cocaine r = .88; Alcohol r = .97; Cigarette r = .91). Cocaine demand elasticity was positively correlated with alcohol and cigarette elasticity. Exponentiated parameters were associated with real-world drug use (e.g., weekly cocaine use) whereas these correlations were less consistent for exponential parameters. Our findings show that selection of zero replacement values affects demand parameters and their association with drug-use outcomes when using the exponential model but not the exponentiated model. This work supports the adoption of the exponentiated demand model by replicating improved fit and consistency and demonstrating construct validity and generalizability. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27929347      PMCID: PMC5157700          DOI: 10.1037/pha0000096

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  44 in total

1.  Modeling drug consumption in the clinic using simulation procedures: demand for heroin and cigarettes in opioid-dependent outpatients.

Authors:  E A Jacobs; W K Bickel
Journal:  Exp Clin Psychopharmacol       Date:  1999-11       Impact factor: 3.157

2.  Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers.

Authors:  James MacKillop; James G Murphy; Lara A Ray; Daniel T A Eisenberg; Stephen A Lisman; J Koji Lum; David S Wilson
Journal:  Exp Clin Psychopharmacol       Date:  2008-02       Impact factor: 3.157

3.  Is talk "cheap"? An initial investigation of the equivalence of alcohol purchase task performance for hypothetical and actual rewards.

Authors:  Michael T Amlung; John Acker; Monika K Stojek; James G Murphy; James MacKillop
Journal:  Alcohol Clin Exp Res       Date:  2011-10-21       Impact factor: 3.455

Review 4.  Power failure: why small sample size undermines the reliability of neuroscience.

Authors:  Katherine S Button; John P A Ioannidis; Claire Mokrysz; Brian A Nosek; Jonathan Flint; Emma S J Robinson; Marcus R Munafò
Journal:  Nat Rev Neurosci       Date:  2013-04-10       Impact factor: 34.870

5.  The effect of drink price and next-day responsibilities on college student drinking: a behavioral economic analysis.

Authors:  Jessica R Skidmore; James G Murphy
Journal:  Psychol Addict Behav       Date:  2011-03

6.  Further evidence of close correspondence for alcohol demand decision making for hypothetical and incentivized rewards.

Authors:  Michael Amlung; James MacKillop
Journal:  Behav Processes       Date:  2015-02-21       Impact factor: 1.777

Review 7.  Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.

Authors:  Brian D Kiluk; Kathleen M Carroll; Amy Duhig; Daniel E Falk; Kyle Kampman; Shengan Lai; Raye Z Litten; David J McCann; Ivan D Montoya; Kenzie L Preston; Phil Skolnick; Constance Weisner; George Woody; Redonna Chandler; Michael J Detke; Kelly Dunn; Robert H Dworkin; Joanne Fertig; Jennifer Gewandter; F Gerard Moeller; Tatiana Ramey; Megan Ryan; Kenneth Silverman; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2015-11-21       Impact factor: 4.492

8.  Differential sensitivity to learning from positive and negative outcomes in cocaine users.

Authors:  Justin C Strickland; B Levi Bolin; Joshua A Lile; Craig R Rush; William W Stoops
Journal:  Drug Alcohol Depend       Date:  2016-06-27       Impact factor: 4.492

9.  A behavioral economic analysis of the nonmedical use of prescription drugs among young adults.

Authors:  Alison M Pickover; Bryan G Messina; Christopher J Correia; Kimberly B Garza; James G Murphy
Journal:  Exp Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.157

10.  Effects of varenicline on abstinence and smoking reward following a programmed lapse.

Authors:  Erin A McClure; Ryan G Vandrey; Matthew W Johnson; Maxine L Stitzer
Journal:  Nicotine Tob Res       Date:  2012-05-09       Impact factor: 4.244

View more
  15 in total

1.  Baseline cocaine demand predicts contingency management treatment outcomes for cocaine-use disorder.

Authors:  Jin H Yoon; Robert Suchting; Sarah A McKay; Guadalupe G San Miguel; Anka A Vujanovic; Angela L Stotts; Scott D Lane; Jessica N Vincent; Michael F Weaver; Austin Lin; Joy M Schmitz
Journal:  Psychol Addict Behav       Date:  2019-06-24

2.  Unique prediction of cannabis use severity and behaviors by delay discounting and behavioral economic demand.

Authors:  Justin C Strickland; Joshua A Lile; William W Stoops
Journal:  Behav Processes       Date:  2017-03-24       Impact factor: 1.777

3.  Using crowdsourcing to examine behavioral economic measures of alcohol value and proportionate alcohol reinforcement.

Authors:  Vanessa Morris; Michael Amlung; Brent A Kaplan; Derek D Reed; Tashia Petker; James MacKillop
Journal:  Exp Clin Psychopharmacol       Date:  2017-06-19       Impact factor: 3.157

Review 4.  Behavioral economic demand as a unifying language for addiction science: Promoting collaboration and integration of animal and human models.

Authors:  Justin C Strickland; Ryan T Lacy
Journal:  Exp Clin Psychopharmacol       Date:  2020-02-27       Impact factor: 3.157

5.  Sensitivity of hypothetical purchase task indices when studying substance use: A systematic literature review.

Authors:  Ivori Zvorsky; Tyler D Nighbor; Allison N Kurti; Michael DeSarno; Gideon Naudé; Derek D Reed; Stephen T Higgins
Journal:  Prev Med       Date:  2019-08-07       Impact factor: 4.018

Review 6.  Clinical models of decision making in addiction.

Authors:  Mikhail N Koffarnus; Brent A Kaplan
Journal:  Pharmacol Biochem Behav       Date:  2017-08-26       Impact factor: 3.533

7.  E-Cigarette Demand: Impact of Commodity Definitions and Test-Retest Reliability.

Authors:  Justin C Strickland; Olga A Vsevolozhskaya; William W Stoops
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

8.  (Non-) impact of task experience on behavioral economic decision-making.

Authors:  Justin C Strickland; B Levi Bolin; Katherine R Marks
Journal:  Exp Clin Psychopharmacol       Date:  2021-02-22       Impact factor: 3.492

9.  Initial development of a brief assessment of cocaine demand.

Authors:  Jin H Yoon; Constanza de Dios; Robert Suchting; Jessica N Vincent; Sarah A McKay; Scott D Lane; Joy M Schmitz
Journal:  Behav Pharmacol       Date:  2021-06-01       Impact factor: 2.277

10.  Behavioral Economic Assessment of Alcohol and Cigarette Demand in Smokers With Alcohol Use Disorder.

Authors:  Yong Cui; Paulina Linares Abrego; Jin Ho Yoon; Maher Karam-Hage; Paul M Cinciripini; Nassima Ait-Daoud Tiouririne; Robert M Anthenelli; Jason D Robinson
Journal:  Front Psychiatry       Date:  2021-06-23       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.